Acute ischemic stroke [9]

New England Journal of Medicine

Volumn 357, Issue 21, 2007, Pages 2203-2204

  Chiti, Alberto ^a   Giorli, Elisa ^a   Orlandi, Giovanni ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; DESMOTEPLASE; FIBRINOLYTIC AGENT; TENECTEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

AGE; CEREBROVASCULAR ACCIDENT; DRUG INDICATION; FIBRINOLYTIC THERAPY; HUMAN; LETTER; PATIENT SELECTION; PRIORITY JOURNAL; ACUTE DISEASE; AGED; BRAIN ISCHEMIA; NOTE; PRACTICE GUIDELINE; STROKE;

ACUTE DISEASE; AGE FACTORS; AGED, 80 AND OVER; BRAIN ISCHEMIA; HUMANS; PRACTICE GUIDELINES AS TOPIC; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 36348986744     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc072590     Document Type: Article

References (4)

1. van der Worp HB, van Gijn J. Acute ischemic stroke. N Engl J Med 2007;357:572-9.
2. Wahlgren N, Ahmed N, Dávalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007;369:275-82. [Erratum, Lancet 2007;369:826.]
3. Sylaja PN, Cote R, Buchan AM, Hill MD. Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study. J Neurol Neurosurg Psychiatry 2006;77:826-9.
4. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 2007;115(20):e478-e534.